Biotechnology News

January 7, 2013

FREMONT, Calif.--(BUSINESS WIRE)--Nitinol Devices & Components (NDC) today announced the appointment of Doug Hutchison as its Chief Commercial Officer effective December 31, 2012 to oversee all of NDC’s commercial activities relating to the...

January 7, 2013

CARLSBAD, Calif.--(BUSINESS WIRE)--GenASIs Go-Path positions ASI as a leader in computer aided pathology immunohistochemistry analysis for cancer and other IHC applications.

January 7, 2013

LINKÖPING, Sweden--(BUSINESS WIRE)--Regulatory News: SECTRA (STO:SECTB): Seven Hudson Valley locations of Orthopedic Associates of Dutchess County (OADC) are now using PACS from the medical imaging IT company Sectra (...

January 7, 2013

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (“EPIRUS”), formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade® in a single dose comparator trial. In February 2012, the United...

January 7, 2013

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal...

January 6, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today its key “Alnylam 5x15™” pipeline and partner program goals for 2013 through 2014. “In 2012, we made tremendous...

January 6, 2013

SAN FRANCISCO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today outlined the company’s strategy and defined key 2013 business priorities to support continued growth and the creation of long-term shareholder value. Vertex’...

January 6, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced a business update, including preliminary fourth quarter 2012 financial results and its outlook for 2013. The company will present further details at the...

January 5, 2013

DENVER--(BUSINESS WIRE)--DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will participate in the 31st Annual J.P. Morgan Healthcare Conference being held January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco, CA...

January 4, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB: SNTI) announced today that it has entered into a securities purchase agreement to raise approximately $3.0 million in gross proceeds through the...

January 4, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 31st Annual JPMorgan Healthcare Conference in San Francisco. John C. Martin, PhD, Gilead’s...

January 4, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to two new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employees were granted stock...

January 4, 2013

GREAT NECK, N.Y.--(BUSINESS WIRE)--Brain & Behavior Research Foundation (formerly NARSAD/Nat. Alliance for Research on Schizophrenia & Depression) for mental health research names psychiatrist Jeffrey Borenstein, M.D., Acting President

January 4, 2013

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24

January 4, 2013

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, announces that Mr. Douglas Doerfler, President & CEO of MaxCyte, will present a business and technical update during...

January 4, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek appoints industry veteran David King as Executive Chairman

January 4, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the completion of a debt offering of $175 million. Ironwood intends to use the net proceeds from this transaction to fund its research and...

January 4, 2013

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced that it will present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 3:00 p.m. (PT). The live webcast of Baxter’s presentation...

January 4, 2013

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions announced today that 2012 marked the greatest overall level of growth in the history of the company with respect to bookings, customer base, headcount, and facilities size. New bookings increased over...

January 4, 2013

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's chairman and chief executive officer, is scheduled to present at the 31st Annual J.P...

January 4, 2013

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the 31st Annual J.P. Morgan Healthcare...

January 4, 2013

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc. announced today that Mary Szela has been appointed to its Board of Directors as its Chair.

January 4, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of Oxymorphone Hydrochloride Extended-Release Tablets, through Global Pharmaceuticals, Impax’s generics division. In June...

January 4, 2013

SAN DIEGO--(BUSINESS WIRE)--Cytori to present at Biotech Showcase 2013 on January 8 at 11:30 AM PT. CEO Chris Calhoun will be on the State of the Industry Briefing panel hosted by the Alliance for Regenerative Medicine.

January 4, 2013

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc...

January 4, 2013

SAN FRANCISCO--(BUSINESS WIRE)--CollabRx to present at Biotech Showcase in San Francisco on Wednesday, Jan 9. CollabRx is a data analytics company that uses cloud-based expert systems to inform health care decision making.

January 4, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the appointment of Pierre Cassigneul as the company’s new chief executive officer. Mr. Cassigneul is a seasoned...

January 4, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that Chief Executive...

January 3, 2013

PASADENA, Calif.--(BUSINESS WIRE)--Genervon will present at Biotech Showcase 2013 its neuroprotective peptide GM604 regulates over 4000 genes, modulates 30 ALS genes, 8 pathways, delayed ALS disease onset by 27%, extended life by 30%.

January 3, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the pricing of its previously announced...

January 3, 2013

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at The 31st Annual J.P. Morgan Healthcare...

January 3, 2013

SEATTLE--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP, a law firm dedicated to representing whistleblowers today announced that its client, Marshall S. Horwitz, M.D., Ph.D., of Seattle, Wash., played a key role in uncovering an illegal scheme...

January 3, 2013

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Ceres Announces Webcast of Fiscal First Quarter 2013 Financial Results

January 3, 2013

HOUSTON--(BUSINESS WIRE)--Smart Imaging Technologies has signed a license agreement with Hamamatsu Photonics and added support for Nanozoomer digital slide scanners to the Simagis Live Digital Slide Management System. Pathologists can catalog,...

January 3, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics appoints Scott Snyder as Chief Marketing Officer

January 3, 2013

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the company's chief executive officer, will present at the 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 1:00 p.m....

January 3, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Ranbaxy Laboratories Inc. has fully deployed the company’s groundbreaking Life Sciences compliance solution suite, including the market leading...

January 3, 2013

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--The Vaccine & Gene Therapy Institute of Florida (VGTI Florida), a leading nonprofit immunological research institute, announces the appointment of Keith Knutson, Ph.D., Program Director.

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics, Inc., an innovative molecular diagnostics company will participate in the 2013 Biotech Showcase in San Francisco, CA.

January 3, 2013

EAGAN, Minn.--(BUSINESS WIRE)--Dr. John Atkinson has joined the Research Advisory Board of Biothera, a biotech company developing an immunotherapeutic oncology drug called Imprime PGG.

January 3, 2013

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT received approval from the FDA to conduct a controlled evaluation of the polymorphonuclear (PMN) cell collection protocol on its next-generation apheresis system, the Spectra Optia system.

January 3, 2013

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--The superiority of STENTYS Self-Apposing stents over conventional stents has been shown in a study published in the Journal of the American College of Cardiology: Cardiovascular Interventions.

January 3, 2013

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the signature of an assurance...

January 3, 2013

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment diseases such as cancer or infectious and...

January 3, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--According to a new Cutting Edge Information study, planning upfront is key to the success of finalizing a study on time.

January 3, 2013

NEW YORK--(BUSINESS WIRE)--‘China Forum III’ to Lead Off 6th Annual ‘OneMedForum’

January 3, 2013

DURHAM, N.C.--(BUSINESS WIRE)--CED announces keynote speakers for life science industry conference, including CMO of WellPoint, CEO of Onyx Pharmaceuticals, and a Nobel Prize winner. Premier biotech and medtech event in Southeast.

January 3, 2013

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medicals’ CEO Bob Ward to present at ‘OneMedForum 2013’ next week in San Francisco